MS
VIVO

Maven Securities’s Meridian Bioscience Inc VIVO Stock Holding History

Maven Securities’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,600
Closed -$850K – 1112
2022
Q4 		$850K Buy
+25,600
New +$825K 0.02% 458

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Maven Securities's VIVO Position: Q1 2023 in Review

Maven Securities sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 25,600 shares — an estimated $850K sold.

Maven Securities first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $850K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Maven Securities reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Maven Securities sold 25,600 Meridian Bioscience Inc shares in Q1 2023, an estimated $850K.
  • Maven Securities first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
  • Maven Securities's Meridian Bioscience Inc position peaked at $850K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Maven Securities's 13F filing for Q1 2023, filed 15 May 2023.